Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
News|Articles|September 30, 2025
3 conferences to watch in Q4 2025
Author(s)Morgan Ebert
Fact checked by: Celeste Krewson, Assistant Editor
Check out the top conferences happening in the fourth quarter of 2025.
Advertisement
Advertisement
As we move into the final stretch of 2025, ob-gyns are turning their attention to a series of major scientific conferences poised to deliver key clinical updates that could shape patient care in the months ahead.
Related to this article
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Advertisement
Advertisement